Cure Rate for Experimental Hepatitis C Drug Tops 95 Percent – WebMD

April 11, 2014 9:46 PM

29 0

THURSDAY, April 10, 2014 (HealthDay News) -- Researchers report that an experimental drug has cured more than 95 percent of patients infected with hepatitis C, including some who failed other treatments.

If it wins approval from the U.S. Food and Drug Administration, this new drug, called ABT-450, could potentially compete with another innovative hepatitis C medication that costs $1,000 a day.

Read more

To category page